US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.776
  • +0.012+1.55%
Close Sep 13 16:00 ET
  • 0.776
  • 0.0000.00%
Post 20:02 ET
30.66MMarket Cap-1615P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-51.59%3.07M
-34.58%3.83M
-25.94%22.92M
-30.28%5.5M
-34.60%5.22M
-17.60%6.34M
-20.61%5.85M
9.14%30.95M
24.01%7.89M
-40.29%7.99M
Selling and administrative expenses
-40.51%1.06M
-22.89%1.28M
-5.14%7.43M
5.40%2.19M
-2.25%1.8M
-2.05%1.78M
-20.81%1.66M
68.84%7.83M
-12.06%2.08M
125.50%1.84M
-General and administrative expense
-40.51%1.06M
-22.89%1.28M
-5.14%7.43M
5.40%2.19M
-2.25%1.8M
-2.05%1.78M
-20.81%1.66M
68.84%7.83M
-12.06%2.08M
125.50%1.84M
Research and development costs
-59.64%1.84M
-39.20%2.55M
-32.99%15.49M
-43.04%3.31M
-44.27%3.43M
-22.42%4.56M
-20.54%4.19M
65.51%23.12M
47.14%5.81M
84.45%6.15M
Other operating expenses
--169.41K
----
----
----
----
----
----
----
----
----
Operating profit
51.59%-3.07M
34.58%-3.83M
25.94%-22.92M
30.28%-5.5M
34.60%-5.22M
17.60%-6.34M
20.61%-5.85M
-9.14%-30.95M
-24.01%-7.89M
40.29%-7.99M
Net non-operating interest income expense
-73.80%38.36K
-90.11%16.62K
82.87%463.26K
-69.20%41.53K
15.41%107.29K
454.99%146.39K
19,917.81%168.06K
110.42%253.32K
8,815.90%134.84K
110.55%92.96K
Non-operating interest income
-73.80%38.36K
-90.11%16.62K
82.87%463.26K
-69.20%41.53K
15.41%107.29K
--146.39K
--168.06K
--253.32K
--134.84K
--92.96K
Other net income (expense)
330.92K
-100.00%-10
99.88%-18
-100.00%8
368.41%2.7M
-102.57%-15.37K
16,851.62%1.56M
Other non- operating income (expenses)
--330.92K
----
-100.00%-10
99.88%-18
-100.00%8
----
----
1,118.79%2.7M
-102.57%-15.37K
528.34%1.56M
Income before tax
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
Income tax
Net income
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
Net income continuous Operations
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
Minority interest income
Net income attributable to the parent company
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
Basic earnings per share
61.11%-0.07
35.29%-0.11
21.69%-0.65
34.78%-0.15
21.05%-0.15
0.00%-0.18
26.09%-0.17
28.45%-0.83
-33.57%-0.23
56.23%-0.19
Diluted earnings per share
61.11%-0.07
35.29%-0.11
21.69%-0.65
34.78%-0.15
21.05%-0.15
0.00%-0.18
26.09%-0.17
28.45%-0.83
-33.57%-0.23
56.23%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -51.59%3.07M-34.58%3.83M-25.94%22.92M-30.28%5.5M-34.60%5.22M-17.60%6.34M-20.61%5.85M9.14%30.95M24.01%7.89M-40.29%7.99M
Selling and administrative expenses -40.51%1.06M-22.89%1.28M-5.14%7.43M5.40%2.19M-2.25%1.8M-2.05%1.78M-20.81%1.66M68.84%7.83M-12.06%2.08M125.50%1.84M
-General and administrative expense -40.51%1.06M-22.89%1.28M-5.14%7.43M5.40%2.19M-2.25%1.8M-2.05%1.78M-20.81%1.66M68.84%7.83M-12.06%2.08M125.50%1.84M
Research and development costs -59.64%1.84M-39.20%2.55M-32.99%15.49M-43.04%3.31M-44.27%3.43M-22.42%4.56M-20.54%4.19M65.51%23.12M47.14%5.81M84.45%6.15M
Other operating expenses --169.41K------------------------------------
Operating profit 51.59%-3.07M34.58%-3.83M25.94%-22.92M30.28%-5.5M34.60%-5.22M17.60%-6.34M20.61%-5.85M-9.14%-30.95M-24.01%-7.89M40.29%-7.99M
Net non-operating interest income expense -73.80%38.36K-90.11%16.62K82.87%463.26K-69.20%41.53K15.41%107.29K454.99%146.39K19,917.81%168.06K110.42%253.32K8,815.90%134.84K110.55%92.96K
Non-operating interest income -73.80%38.36K-90.11%16.62K82.87%463.26K-69.20%41.53K15.41%107.29K--146.39K--168.06K--253.32K--134.84K--92.96K
Other net income (expense) 330.92K-100.00%-1099.88%-18-100.00%8368.41%2.7M-102.57%-15.37K16,851.62%1.56M
Other non- operating income (expenses) --330.92K-----100.00%-1099.88%-18-100.00%8--------1,118.79%2.7M-102.57%-15.37K528.34%1.56M
Income before tax 56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M
Income tax
Net income 56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M
Net income continuous Operations 56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M
Minority interest income
Net income attributable to the parent company 56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M
Basic earnings per share 61.11%-0.0735.29%-0.1121.69%-0.6534.78%-0.1521.05%-0.150.00%-0.1826.09%-0.1728.45%-0.83-33.57%-0.2356.23%-0.19
Diluted earnings per share 61.11%-0.0735.29%-0.1121.69%-0.6534.78%-0.1521.05%-0.150.00%-0.1826.09%-0.1728.45%-0.83-33.57%-0.2356.23%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data